Name
Capella University
NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care
Prof. Name
Date
This evaluation is designed to provide a thorough understanding of a patient’s overall health by integrating subjective symptoms, observable clinical signs, and functional assessments. Specific attention is given to blood glucose control, cardiovascular health, and foot condition, as these factors are particularly relevant for patients with diabetes. These assessments help identify early complications, guide interventions, and support the development of a personalized care plan that aligns with the patient’s health goals. The objective is to detect problems early and foster behaviors that improve health outcomes.
Hello, I am your nurse today. Since this is a video assessment, I will guide you through each part and ask you to describe or show certain things so I can get a complete picture of your health.
You appeared alert, oriented, and able to communicate clearly. The patient reports obtaining approximately eight hours of sleep nightly. Home vital signs include a blood pressure averaging 140/85 mmHg and a heart rate between 78–82 bpm. Blood glucose readings ranged from 130–140 mg/dL, and the most recent hemoglobin A1C was 8.9%.
The patient’s medical history includes hypertension, hyperlipidemia, and newly diagnosed type 2 diabetes mellitus. Current medications include:
| Medication | Dose | Purpose |
|---|---|---|
| Metoprolol | 50 mg twice daily | Blood pressure control, cardiovascular protection |
| Atorvastatin | 80 mg daily | Cholesterol management, vascular protection |
| Gabapentin | As prescribed | Neuropathic pain relief |
| Tung seed | As herbal supplement | Traditional use; potential interactions with cardiac medications |
Family history reveals a predisposition to metabolic and cardiovascular conditions: the mother had alcoholism, hyperlipidemia, and diabetes; the father had hypertension and high cholesterol; the paternal grandfather experienced diabetes leading to left leg amputation; the maternal grandfather had diabetes and was on dialysis. The patient follows a moderately active lifestyle, including 30-minute walks on weekends, and consumes a diet that includes both fresh and processed foods.
Your eyes seem clear, and your eyelids appear healthy, with no signs of jaundice or redness. You do not have blurred vision; however, close evaluation is required because diabetes can affect the eyes even in the absence of symptoms.
Oral assessment revealed slight dryness of the mouth and lips, consistent with reported polydipsia.
You report tingling and burning sensations in both feet. What is the level of your pain on a scale of 0–10?
The visual analog pain scale indicated a 5/10 intensity. No abnormal movements of arms or legs were noted. Self-reported sensory testing revealed decreased sensation to sharp and dull stimuli in both feet. The patient denied weakness, numbness, or dizziness beyond occasional lightheadedness.
Feet and lower legs showed no open wounds but mild dryness. Skin color was normal, without cyanosis. Pulses in the dorsalis pedis and posterior tibial arteries were palpable but slightly diminished. Skin temperature was generally warm, with toes slightly cooler than the upper leg, suggesting early ischemic changes. No edema was present.
Do you experience chest pain, palpitations, or shortness of breath?
The patient denied these symptoms. Heart rate was regular. The presence of a stenotic murmur at the fourth intercostal space was previously documented, suggesting possible arterial narrowing.
The assessment priorities include observation of general appearance, neurological evaluation, peripheral circulation monitoring, medication review, and guidance on management of diabetes, cardiovascular risk, and neuropathy.
The most significant findings were elevated blood sugar, peripheral neuropathy symptoms (tingling and burning), and a history of hypertension and hyperlipidemia. Hemoglobin A1C of 8.9% indicates prolonged hyperglycemia, which damages small blood vessels and nerves, particularly in the feet (Bodman & Varacallo, 2024).
Why are these findings significant?
Family history of diabetes and the patient’s own metabolic conditions increase risk for complications. Reduced circulation from hypertension and hyperlipidemia can exacerbate neuropathic symptoms. The overall diagnosis is Type 2 diabetes mellitus with peripheral neuropathy.
Management goals focus on three key areas:
Lowering blood glucose to prevent nerve damage
Relieving neuropathic pain
Minimizing cardiovascular risk
Medications prescribed and their purpose:
| Medication | Purpose | Notes/Precautions |
|---|---|---|
| Metformin | Lowers blood sugar | May cause gastrointestinal upset initially |
| Gabapentin | Neuropathic pain relief | Can cause dizziness, drowsiness |
| Atorvastatin | Cholesterol control, vascular protection | May cause muscle aches |
| Metoprolol | Blood pressure management | Reduces cardiac strain, improves circulation |
Monitoring for side effects, drug interactions (including herbal supplements like Tung seed), and adherence is essential. The patient is advised to report swelling, worsening numbness, severe dizziness, or chest pain immediately (Cleveland Clinic, 2025; Mayo Clinic, 2024).
Key components of patient education include:
Medication adherence – Take medications as prescribed, monitor for side effects.
Blood glucose monitoring – Check levels daily and maintain a balanced diet.
Physical activity – Regular exercise improves circulation and supports glycemic control.
Foot care – Daily inspection, proper footwear, and protection from injury reduce risk of infection and ulceration (American Diabetes Association, 2024).
This plan emphasizes understanding, demonstration, and patient engagement to ensure confidence in self-care.
Type 2 diabetes results from insulin resistance, preventing glucose from entering cells for energy and causing hyperglycemia (CDC, 2024). Chronic high blood sugar leads to microvascular and nerve damage, manifesting as peripheral neuropathy with tingling, burning, or sharp foot pain (Yachmaneni et al., 2023). Without intervention, neuropathy worsens, increasing the risk of unnoticed injuries, infections, and complications. Symptoms such as thirst, fatigue, and blurry vision reflect systemic effects of sustained hyperglycemia.
Primary care priorities are:
Stabilize blood glucose
Protect nerves and peripheral circulation
Reduce cardiovascular risk
Promote preventive daily habits
Elevated A1C and vascular comorbidities increase risk for progressive neuropathy and cardiovascular complications. Medication support, lifestyle interventions, and education are vital components of care. Strict glucose management, routine foot assessments, and early detection of neuropathy align with ADA recommendations (American Diabetes Association, 2023).
Collaboration between the patient and healthcare provider is essential for successful management of Type 2 diabetes and peripheral neuropathy. Through proper medication use, lifestyle modifications, and vigilant self-care, complications can be minimized, and quality of life maintained. Continuous guidance and patient engagement are crucial for long-term success.
American Diabetes Association (ADA). (2023). American diabetes association releases 2023 standards of care in diabetes to guide prevention, diagnosis, and treatment for people living with diabetes | ADA. Diabetes.org. https://diabetes.org/newsroom/american-diabetes-association-2023-standards-care-diabetes-guide-for-prevention-diagnosis-treatment-people-living-with-diabetes
Bays, H. (2021). Ten things to know about ten cardiovascular disease risk factors. American Journal of Preventive Cardiology, 5(100149), 100149. https://doi.org/10.1016/j.ajpc.2021.100149
Bodman, M. A., & Varacallo, M. (2024). Diabetic neuropathy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK442009/
Centers for Disease Control and Prevention (CDC). (2024, May 15). About insulin resistance and type 2 diabetes. Diabetes. https://www.cdc.gov/diabetes/about/insulin-resistance-type-2-diabetes.html
Cleveland Clinic. (2025, March 4). Side effects of metformin: Watch out for these signs. Cleveland Clinic. https://health.clevelandclinic.org/side-effects-of-metformin
Mayo Clinic. (2024). Atorvastatin (oral route) description and brand names. www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20067003
Yachmaneni, A., Jajoo, S., Mahakalkar, C., Kshirsagar, S., & Dhole, S. (2023). A comprehensive review of the vascular consequences of diabetes in the lower extremities: Current approaches to management and evaluation of clinical outcomes. Cureus, 15(10). https://doi.org/10.7759/cureus.47525
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025). Diabetic neuropathy: Cutting-edge research and future directions. Signal Transduction and Targeted Therapy, 10(1). https://doi.org/10.1038/s41392-025-02175-1
